Palatin Technologies, Inc. Common Stock
Market Cap
25M
Short interest (May 15)
8.8%
Net Short (Jun 03 ): -0.1%
Borrow Fee
12.00%
↑ 1.7%
Available Shares
30K
↓ 1.3%
Price Chart
Company Overview
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.